Heffeter P - Search Results

1

Structure-Activity Relationships of Triple-Action Platinum(IV) Prodrugs with Albumin-Binding Properties and Immunomodulating Ligands.

Fronik P, Poetsch I, Kastner A, Mendrina T, Hager S, Hohenwallner K, Schueffl H, Herndler-Brandstetter D, Koellensperger G, Rampler E, Kopecka J, Riganti C, Berger W, Keppler BK, Heffeter P, Kowol CR. Fronik P, et al. Among authors: heffeter p. J Med Chem. 2021 Aug 26;64(16):12132-12151. doi: 10.1021/acs.jmedchem.1c00770. Epub 2021 Aug 17. J Med Chem. 2021. PMID: 34403254 Free PMC article.

2

Intrinsic and acquired forms of resistance against the anticancer ruthenium compound KP1019 [indazolium trans-[tetrachlorobis(1H-indazole)ruthenate (III)] (FFC14A).

Heffeter P, Pongratz M, Steiner E, Chiba P, Jakupec MA, Elbling L, Marian B, Körner W, Sevelda F, Micksche M, Keppler BK, Berger W. Heffeter P, et al. J Pharmacol Exp Ther. 2005 Jan;312(1):281-9. doi: 10.1124/jpet.104.073395. Epub 2004 Aug 26. J Pharmacol Exp Ther. 2005. PMID: 15331656

3

Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells.

Kapitza S, Pongratz M, Jakupec MA, Heffeter P, Berger W, Lackinger L, Keppler BK, Marian B. Kapitza S, et al. Among authors: heffeter p. J Cancer Res Clin Oncol. 2005 Feb;131(2):101-10. doi: 10.1007/s00432-004-0617-0. Epub 2004 Oct 16. J Cancer Res Clin Oncol. 2005. PMID: 15503135

4

Anticancer activity of the lanthanum compound [tris(1,10-phenanthroline)lanthanum(III)]trithiocyanate (KP772; FFC24).

Heffeter P, Jakupec MA, Körner W, Wild S, von Keyserlingk NG, Elbling L, Zorbas H, Korynevska A, Knasmüller S, Sutterlüty H, Micksche M, Keppler BK, Berger W. Heffeter P, et al. Biochem Pharmacol. 2006 Feb 14;71(4):426-40. doi: 10.1016/j.bcp.2005.11.009. Epub 2005 Dec 15. Biochem Pharmacol. 2006. PMID: 16343446

5

Anticancer effects of zoledronic acid against human osteosarcoma cells.

Kubista B, Trieb K, Sevelda F, Toma C, Arrich F, Heffeter P, Elbling L, Sutterlüty H, Scotlandi K, Kotz R, Micksche M, Berger W. Kubista B, et al. Among authors: heffeter p. J Orthop Res. 2006 Jun;24(6):1145-52. doi: 10.1002/jor.20129. J Orthop Res. 2006. PMID: 16602111 Free article.

6

Enniatin exerts p53-dependent cytostatic and p53-independent cytotoxic activities against human cancer cells.

Dornetshuber R, Heffeter P, Kamyar MR, Peterbauer T, Berger W, Lemmens-Gruber R. Dornetshuber R, et al. Among authors: heffeter p. Chem Res Toxicol. 2007 Mar;20(3):465-73. doi: 10.1021/tx600259t. Epub 2007 Feb 28. Chem Res Toxicol. 2007. PMID: 17326668

7

Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24).

Heffeter P, Jakupec MA, Körner W, Chiba P, Pirker C, Dornetshuber R, Elbling L, Sutterlüty H, Micksche M, Keppler BK, Berger W. Heffeter P, et al. Biochem Pharmacol. 2007 Jun 15;73(12):1873-86. doi: 10.1016/j.bcp.2007.03.002. Epub 2007 Mar 12. Biochem Pharmacol. 2007. PMID: 17445775 Free PMC article.

8

Metal-based paullones as putative CDK inhibitors for antitumor chemotherapy.

Schmid WF, John RO, Mühlgassner G, Heffeter P, Jakupec MA, Galanski MS, Berger W, Arion VB, Keppler BK. Schmid WF, et al. Among authors: heffeter p. J Med Chem. 2007 Dec 13;50(25):6343-55. doi: 10.1021/jm701042w. Epub 2007 Nov 13. J Med Chem. 2007. PMID: 17997519

9

Resistance against novel anticancer metal compounds: differences and similarities.

Heffeter P, Jungwirth U, Jakupec M, Hartinger C, Galanski MS, Elbling L, Micksche M, Keppler B, Berger W. Heffeter P, et al. Drug Resist Updat. 2008 Feb-Apr;11(1-2):1-16. doi: 10.1016/j.drup.2008.02.002. Epub 2008 Apr 3. Drug Resist Updat. 2008. PMID: 18394950 Review.

10

Ribonucleotide reductase as one important target of [Tris(1,10-phenanthroline)lanthanum(III)] trithiocyanate (KP772).

Heffeter P, Popovic-Bijelic A, Saiko P, Dornetshuber R, Jungwirth U, Voevodskaya N, Biglino D, Jakupec MA, Elbling L, Micksche M, Szekeres T, Keppler BK, Gräslund A, Berger W. Heffeter P, et al. Curr Cancer Drug Targets. 2009 Aug;9(5):595-607. doi: 10.2174/156800909789056962. Epub 2009 Aug 1. Curr Cancer Drug Targets. 2009. PMID: 19508176 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters